[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Tue, May 5th, 2026

Cannabis Stocks Profiles

View company profiles of publicly traded cannabis, marijuana, and 420 friendly Stocks.
Tue, May 5th, 2026

Cannabis/marijuana stocks represent new investment opportunities as public companies provide products and services for medical and recreational use. Worldwide spending on legal cannabis reached $21.3 billion in 2020 and some analysts expect that that number could surpass $50 billion if nationwide legalization were to occur. Given this potential opportunity, investors are now speculating which marijuana-related stocks could become the dominant players in the future. Barchart’s cannabis stocks list is a great starting point that will allow you to find investment opportunities and compare stocks involved in the growing cannabis industry.

Cronos Group Inc (CRON.TO)

Full Profile

Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.

52-Week Low
52-Week High
2.52
4.66

Overview:

Market Capitalization, $K 1,365,865
Shares Outstanding, K 376,271
Last Quarter Sales 44,531 K
Last Quarter Net Income -1,816 K
% Insider Shareholders N/A
% Institutional Shareholders 4.36%

Organigram Global Inc (OGI.TO)

Full Profile

Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.

52-Week Low
52-Week High
1.51
3.09

Overview:

Market Capitalization, $K 265,803
Shares Outstanding, K 140,636
Last Quarter Sales 63,538 K
Last Quarter Net Income 19,969 K
% Insider Shareholders N/A
% Institutional Shareholders 4.01%

Aurora Cannabis Inc (ACB.TO)

Full Profile

Aurora Cannabis Inc headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company operates in Canada, it has expanded internationally through medical cannabis exporting agreements. The company opertes in Canada, Europe, Australia, and Others, with majority revenue from Canada.

52-Week Low
52-Week High
4.29
9.33

Overview:

Market Capitalization, $K 274,939
Shares Outstanding, K 59,127
Last Quarter Sales 94,191 K
Last Quarter Net Income 1,820 K
% Insider Shareholders N/A
% Institutional Shareholders 4.25%

Cardiol Therapeutics Inc (CRDL.TO)

Full Profile

Cardiol Therapeutics Inc is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. Its primary small-molecule candidate, CardiolRx, targets inflammasome pathway activation, which is involved in the development of inflammation and fibrosis in conditions such as pericarditis, myocarditis, and heart failure. The CardiolRx program includes the completed Phase II MAVERIC-Pilot study and the ongoing Phase III MAVERIC trial for the treatment of pericarditis. The ARCHER program evaluated CardiolRx in acute myocarditis through a completed Phase II study. The company is also developing CRD-38, a novel subcutaneous drug formulation for treating inflammatory heart conditions, including heart failure.

52-Week Low
52-Week High
1.23
2.33

Overview:

Market Capitalization, $K 203,258
Shares Outstanding, K 111,680
Last Quarter Sales 0 K
Last Quarter Net Income -7,213 K
% Insider Shareholders N/A
% Institutional Shareholders 0.08%

High Tide Inc (HITI.VN)

Full Profile

High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, and others. The company's reportable operating segments are: Bricks and mortar, which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada, followed by the United States of America, and other international markets.

52-Week Low
52-Week High
2.850
5.590

Overview:

Market Capitalization, $K 290,942
Shares Outstanding, K 87,898
Last Quarter Sales 178,329 K
Last Quarter Net Income 1,205 K
% Insider Shareholders N/A
% Institutional Shareholders 4.86%

Canopy Growth Corporation (WEED.TO)

Full Profile

Canopy Growth Corp, cultivates and sells medicinal and recreational cannabis and hemp through a portfolio of brands that include Doja, LivRelief, Ace Valley, Deep Space, and others. The Company is engaged in reportable segments namely: Canada cannabis, International markets cannabis, Storz & Bickel, and This Works. The company generates maximum revenue from Canadian cannabis.

52-Week Low
52-Week High
1.18
3.28

Overview:

Market Capitalization, $K 642,685
Shares Outstanding, K 422,819
Last Quarter Sales 74,541 K
Last Quarter Net Income -62,627 K
% Insider Shareholders N/A
% Institutional Shareholders 3.57%

Tilray Brands Inc (TLRY.TO)

Full Profile

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.

52-Week Low
52-Week High
4.90
32.30

Overview:

Market Capitalization, $K 959,704
Shares Outstanding, K 119,604
Last Quarter Sales 206,732 K
Last Quarter Net Income -26,572 K
% Insider Shareholders N/A
% Institutional Shareholders 4.07%
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.